Fund Card

Fund Card

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

As on Nov-15-2019 change fund
9.96  down0.00 (0.00%)

fund objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2016-20172018-2019
NAV in Rs (as on 31-Mar-2019)NA10.14
Net Assets(Rs Crores) (as on 31-Mar-2019) _ 1497.55
Scheme Returns(%)(Absolute)NA1.40
B'mark Returns(%)(Absolute)1.346.85
Category Rank297/30237/73
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2019-2020-4.93-2.39NANA
2018-2019NANA-5.362.63
Top 10 holdings
company (%)
Cipla Ltd.10.21 
Sun Pharmaceutical Industries...9.71 
Lupin Ltd.6.47 
Cadila Healthcare Ltd.6.38 
Dr. Reddys Laboratories Ltd.5.82 
Biocon Ltd.5.47 
SBI Life Insurance Company Ltd.4.81 
Sanofi India Ltd.4.76 
Torrent Pharmaceuticals Ltd.4.34 
Laurus Labs Ltd.4.16 

Category

Sector Funds

Launch Date

13-Jul-18

Scheme Benchmark

S&P BSE HEALTH CARE

AUM ( in Cr.)

1,339.10

portfolio price to book value

NA

investing style?

Mid Growth

fund manager?

Ihab Dalwai,Priyanka Khandelwal

inception date (regular plan)

13-Jul-18

expense ratio (regular plan) %

2.18

Alpha [%]

-0.04

Beta [%]

0.44

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs82.99
Hospital & Healthcare Services5.56
Insurance4.81
Chemicals 1.98
Miscellaneous1.48
Finance - Investment0.30

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20181,339.10-0.305.174.95-0.60NANANA-0.30BUYSIP
Nippon India Pharma Fund(G)Mid-Growth 05-Jun-20042,429.66-0.164.105.39-4.071.883.4914.4918.96BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-2015173.630.273.193.311.570.30NANA-2.69BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005392.780.244.825.22-4.07-2.79-0.7511.1015.76BUYSIP
SBI Healthcare Opp Fund-Reg(G)Mid-Growth 14-Jul-1999936.91-1.325.785.94-5.18-5.85-0.4713.1913.66BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Mid-Growth 02-Jul-2018357.92-0.454.475.560.81NANANA3.60BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018235.17-0.226.677.90NANANANA5.40BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Mid-Growth 10-Jul-2019170.53-3.131.791.89NANANANA2.30BUYSIP
IDBI Healthcare Fund-Reg(G)Mid-Growth 28-Feb-201933.170.294.695.99NANANANA2.60BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974